Identification and Optimization of Novel Small c-Abl Kinase Activators Using Fragment and HTS Methodologies
Author:
Affiliation:
1. Medicines Research Centre, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
2. GlaxoSmithKline R&D, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b01872
Reference49 articles.
1. The Protein Kinase Complement of the Human Genome
2. Catalytic Mechanisms and Regulation of Protein Kinases
3. Targeting cancer with small molecule kinase inhibitors
4. Small-molecule kinase inhibitors: an analysis of FDA-approved drugs
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Benchmarking compound activity prediction for real-world drug discovery applications;Communications Chemistry;2024-06-04
2. LC–MS profiling, in vitro and in silico C-ABL kinase inhibitory approach to identify potential anticancer agents from Dalbergia sissoo leaves;Scientific Reports;2024-01-02
3. Discovery of N-(2-oxoethyl) sulfanilamide-derived inhibitors of KAT6A (MOZ) against leukemia by an isostere strategy;European Journal of Medicinal Chemistry;2023-11
4. Development and Applications of Chimera Platforms for Tyrosine Phosphorylation;ACS Central Science;2023-08-09
5. Development and applications of chimera platforms for tyrosine phosphorylation;2023-03-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3